Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech January 5, 2023 Read More
Nimble Therapeutics Delivers Lead Compounds for Two Programs Under Collaboration with Large Pharma Partner, Triggering Milestone Payments December 13, 2022 Read More
Nimble Therapeutics Announces Achievement of Development Milestones from Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration May 17, 2022 Read More
Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics September 14, 2021 Read More
Nimble Therapeutics Appoints Cyrus Arman, PhD, MBA as Chief Business Officer September 8, 2021 Read More
Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals June 28, 2021 Read More
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics October 5, 2020 Read More
